Released Nov 9, 2016, before the open
10-Q filed Nov 9, 2016, 40 days after period end · 0001144204-16-132547
Q3 2016 · 10-Q
Revenue—
Net Income-$11.57M-$11.57M N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.67-$0.67 N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$11,678,925N/M
Operating Cash Flowderived-$7,864,320N/M
Free Cash Flowderived-$7,897,251N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$11.57M | -$6.62M | -$11.02M | -$4.88M |
| EPS Diluted | -$0.67 | -$0.38 | -$1.33 | -$1.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR